Rheinmetall (RHM GY) H1 2026 (EUR): Sales 5.227bln (prev. 3.749bln Y/Y), Operating Result 786mln (prev. 453mln Y/Y); still sees sales between 13.7-14.2bln (exp. 14bln), still sees FY operating margin ~19% (exp. 19.1%)
Newsquawk Staff ·
Rheinmetall (RHM GY) H1 2026 (EUR): Sales 5.227bln (prev. 3.749bln Y/Y), Operating Result 786mln (prev. 453mln Y/Y); still sees sales between 13.7-14.2bln (exp. 14bln), still sees FY operating margin ~19% (exp. 19.1%)
What it means
Defence-sector results of this kind have been trading on a well-established sequence through the European rearmament cycle: order intake and backlog conversion matter more than the half-year print itself, since sales growth at this pace is the market's base case rather than new information. The read here is confirmation of that conversion, with the guidance reiteration carrying more weight than the interim numbers; reiterated full-year sales in line with consensus removes the downside scenario but adds nothing to the bull case. The tell is the margin line, where guidance of roughly 19% sits a touch below the consensus figure, and in prior episodes a marginal shortfall on margin guidance against strong top-line growth has drawn attention to mix and ramp-up costs rather than demand. The distinction worth drawing is between margin pressure from scaling new capacity, which the peer set has generally been forgiven for, and margin pressure from pricing or contract structure, which has not. Follow-ons are the call commentary on order intake versus the elevated expectations now standard for the group, any detail on capacity expansion timelines, and how the result reads across to the broader European defence complex, where correlation on results days has been high.
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone
- Newsquawk Daily US Earnings Estimates - 23rd October 2026: AXP
- China is seeking R&D and supply chain cooperation with Airbus (AIR FP)
- US PREMARKET MOVERS: META, TSLA, IBM, LRCX, BX, PG, CMCSA, SAP, BABA
- US BROKER MOVES: CME upgraded at JPM; BROS downgraded at RBC
Related headlines
- US EQUITY OPEN: Mag-7 earnings lead Tech and Indices lower as the Middle East situation remains fragile6 hours ago
- US President Trump invokes Section 232 on wind turbine imports34 min ago
- US President Trump signs EO on housing costs, aiming to cut mortgage insurance premiums41 min ago
- US President Trump called Musk and asked him to lift Ukraine Starlink (SPCX) restrictions, WSJ reports2 hours ago
- L'Oreal (OR FP) CEO says China market slowed a tiny bit in Q3 but maintained growth rate, favoured by dynamic premium segment3 hours ago
- Kering (KER FP) says traffic remains the main constraint; fashion and leather goods retail sales fell 4% comp., a sequential slowdown reflecting a more challenging environment, less support from Gucci and lower summer traffic, especially in mainland China3 hours ago
- L'Oreal (OR FP) Q3 2026 (EUR): Sales 11.56bln (exp. 11.23bln), Adj. LFL revenue +7.7% (exp. +5.43%); 2026 outlook: sees another year of growth in sales and profit4 hours ago
- US President Trump says "Iran is doing everything they can to drive up the price of Oil prior to the U.S. Midterm Election". 4 hours ago
- Infineum is exploring a USD 8bln sale, the FT reports6 hours ago
- Nokia (NOKIA FH) says Q3 operating margin expanded 220bps Y/Y to 11.7%, with FY26 Group outlook tracking above the midpoint of guidance7 hours ago
- ADNOC's XRG in talks with Eni (ENI IM) over potential acquisition of its stake in the Libya business, according to reports8 hours ago
- American Airlines Group Inc. (AAL) Q3 2026 (USD): adj EPS -0.28 (exp. -0.33), Revenue 16.3bln (exp. 16.20bln); new revenue record. CEO "...expect another quarter of record revenue growth to close out the year."9 hours ago
- German tax panel says federal tax revenue for 2026-2030 is projected to be EUR 3.3bln above the May forecast7 hours ago
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED3 hours ago
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising3 hours ago